-5%
Megestol 160
Breast Cancer:
- Treats cancer cells in the breast by slowing their progression.
- Helps alleviate symptoms like nipple discharge, lumps, and nipple/breast shape changes.
Endometrial Cancer:
- Treats cancer of the uterus lining.
- Reduces associated symptoms like pelvic pain, irregular bleeding, and discomfort during intercourse.
- Occasionally prescribed to manage appetite loss in patients with HIV/AIDS.
Breast cancer is a type of cancer that originates in the cells of the breast. It can develop in various parts of the breast, including:
- Lobules (milk-producing glands)
- Ducts (pathways that carry milk to the nipple)
- Fatty tissue
- Fibrous connective tissue
Symptoms:
- Lump or thickening in the breast that feels different from the surrounding tissue.
- Breast pain or tenderness.
- Redness or swelling in the breast.
- Nipple discharge (other than milk), including bloody discharge.
- Unexplained changes in breast shape, size, or appearance.
- Peeling, flaking, or scaling of the skin on the breast.
- Swelling or lumps under the arm.
Risk Factors:
- Increasing age.
- Family history of breast cancer.
- Obesity.
- Hormonal factors, such as early menstruation or late menopause.
- Genetic mutations, such as BRCA1 and BRCA2 genes.
Endometrial Cancer:
Endometrial cancer affects the endometrium (the lining of the womb or uterus). It typically develops after menopause and is most common in women over the age of 55.
Symptoms:
- Abnormal bleeding between periods or after menopause.
- Pelvic pain.
- Pain during sexual intercourse.
Risk Factors:
- Increasing age (common after menopause).
- Obesity.
- Never having been pregnant (nulliparity).
- Family history of cancer, especially endometrial or colorectal cancer.
- Diabetes.
Prognosis:
- Endometrial cancer is less likely to be life-threatening when diagnosed early and treated promptly, typically through surgery (such as a hysterectomy).